A detailed history of Janus Henderson Group PLC transactions in Novartis Ag stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,541,861 shares of NVS stock, worth $250 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,541,861
Previous 2,548,913 0.28%
Holding current value
$250 Million
Previous $271 Million 7.74%
% of portfolio
0.16%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $748,428 - $852,516
-7,052 Reduced 0.28%
2,541,861 $292 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $1.83 Million - $2.13 Million
-19,815 Reduced 0.77%
2,548,913 $271 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $1.53 Million - $1.74 Million
16,015 Added 0.63%
2,568,728 $248 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $1.82 Million - $2.01 Million
19,776 Added 0.78%
2,552,713 $258 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $6.47 Million - $7.18 Million
-68,329 Reduced 2.63%
2,532,937 $258 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $93.4 Million - $106 Million
-1,009,517 Reduced 27.96%
2,601,266 $262 Million
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $25.8 Million - $29.9 Million
-322,510 Reduced 8.2%
3,610,783 $332 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $44.9 Million - $55 Million
594,023 Added 17.79%
3,933,293 $357 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $11.2 Million - $13.1 Million
149,986 Added 4.7%
3,339,270 $254 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $15.4 Million - $18 Million
-191,601 Reduced 5.67%
3,189,284 $270 Million
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $14.3 Million - $16.2 Million
-178,294 Reduced 5.01%
3,380,885 $297 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $34 Million - $37.6 Million
-426,338 Reduced 10.7%
3,559,179 $311 Million
Q3 2021

Nov 16, 2021

SELL
$81.78 - $95.14 $20.7 Million - $24.1 Million
-253,150 Reduced 5.97%
3,985,517 $326 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $29.2 Million - $32.3 Million
-342,698 Reduced 7.48%
4,238,667 $387 Million
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $7.37 Million - $8.69 Million
-88,236 Reduced 1.89%
4,581,365 $392 Million
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $2.33 Million - $2.82 Million
29,894 Added 0.64%
4,669,601 $441 Million
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $3.94 Million - $4.36 Million
-47,941 Reduced 1.02%
4,639,707 $403 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $18.5 Million - $20.8 Million
228,395 Added 5.12%
4,687,648 $409 Million
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $24.4 Million - $34.2 Million
-345,884 Reduced 7.2%
4,459,253 $368 Million
Q4 2019

Feb 18, 2020

BUY
$84.35 - $95.37 $9.15 Million - $10.3 Million
108,422 Added 2.31%
4,805,137 $455 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $67.8 Million - $74.7 Million
792,759 Added 20.31%
4,696,715 $408 Million
Q2 2019

Jul 31, 2019

BUY
$75.4 - $92.8 $14.1 Million - $17.3 Million
186,461 Added 5.02%
3,903,956 $356 Million
Q1 2019

Apr 30, 2019

BUY
$75.32 - $86.15 $28 Million - $32 Million
371,396 Added 11.1%
3,717,495 $357 Million
Q4 2018

Feb 06, 2019

BUY
$73.66 - $82.02 $5.8 Million - $6.46 Million
78,747 Added 2.41%
3,346,099 $287 Million
Q3 2018

Nov 09, 2018

BUY
$66.94 - $77.43 $49.6 Million - $57.4 Million
741,373 Added 29.35%
3,267,352 $282 Million
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $40 Million - $45.2 Million
615,844 Added 32.24%
2,525,979 $191 Million
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $25.3 Million - $30.3 Million
-360,125 Reduced 15.86%
1,910,135 $154 Million
Q4 2017

Feb 09, 2018

BUY
$72.33 - $77.64 $29.4 Million - $31.5 Million
405,864 Added 21.77%
2,270,260 $191 Million
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $3.72 Million - $3.87 Million
-50,120 Reduced 2.62%
1,864,396 $0
Q2 2017

Aug 17, 2017

BUY
N/A
1,914,516
1,914,516 $160 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.